Aug 04, 2022 / 09:00PM GMT
Operator
My name is Jason, and I will be your conference facilitator today for Amgen's Second Quarter 2022 Financial Results Conference Call. (Operator Instructions)
I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.
Arvind Sood - Amgen Inc. - VP of IR
Okay, Jason, thank you. Good afternoon, everybody, and welcome to our Q2 call. Lots to cover today, so we'll go ahead and jump right in.
Some of the key themes you'll hear about today include continued volume-driven growth, our strategy of seeking both internal and external innovation, the latter exemplified by our announcement this morning of acquiring ChemoCentryx. And lastly, navigating through a difficult macro environment. We have posted the slides for your background, we'll use non-GAAP financial measures in our presentation today and some of the statements will be forward-looking. Our SEC filings identify factors that could cause our actual results to differ materially.
So with that, I would like to turn the call over to our
Q2 2022 Amgen Inc Earnings Call Transcript
Aug 05, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers